TCP Analytical Holdings

Situation

SilverMill and PNC Riverarch Capital engaged G2 Capital Advisors (“G2”) as the buy-side advisor for TCP Analytical, with the mandate of identifying, sourcing, and activating complementary businesses that would extend its geographic footprint. G2’s work led to the acquisition of Lifecycle Biotechnologies, LP (“Lifecycle Biotechnologies”), a Texas-based leader in life sciences manufacturing. Founded in 1978, Lifecycle Biotechnologies produces raw materials and components for emerging bio-pharmaceutical, regenerative medicine, industrial life sciences, and cellular agricultural product manufacturers—building blocks for lifesaving and life-enhancing medical products used globally today.

“Our partnership with Lifecycle Biotechnologies brings us new capabilities with high-value, sterile solutions, and it will also allow us to better serve our customers throughout the country through a new key location,” says Nate Meyer, President of Specialty Manufacturing at TCP. “Together, we are expanding our manufacturing capacity across state-of-the-art facilities and reinforcing our commitment to building a scalable lab supplies manufacturer with a focus on life science research products made here in the US.”

Engagement

Since its inception, TCP Analytical has grown its Specialty Manufacturing and Life Science Distribution channels through the strategic acquisition of companies with unique manufacturing capabilities, strong customer value propositions, and attractive growth profiles. This approach has built strong, long-standing relationships with a diverse and global customer base. TCP Analytical continues to view acquisitions as a strategic priority and sought a value-added advisor to help them navigate the vast landscape of opportunities.

Outcome

“This strategic move seamlessly aligns with our mission to improve scientific outcomes and deliver customer service excellence,” says Al Jurgela, Co-Founder and Managing Member of SilverMill. “We are grateful to G2 Capital Advisors for the team’s unwavering commitment to this transaction. Victoria Arrigoni’s expertise in the industry played a pivotal role in steering us towards a mutually beneficial and successful outcome.”

“It is exciting to see two leading specialty chemical businesses that share a commitment to delivering the highest quality research products, reagents, and analytic testing solutions to their customers.,” said Victoria Arrigoni, Managing Director and Head of Industrials & Manufacturing at G2 Capital Advisors. “We are pleased to support this transaction and energized to realize more successes together.”